Shilpa Gupta, MD

Cleveland Clinic

Cleveland, Ohio

Shilpa Gupta, MD, is the Director of the Genitourinary Medical Oncology at Taussig Cancer Institute and Co-Leader of the Genitourinary Oncology Program at the Cleveland Clinic in Cleveland, Ohio. Dr. Gupta’s research interests include novel drug development and understanding biomarkers of response and resistance to therapies in bladder cancer.

Dr. Gupta earned her medical degree at the Lady Hardinge Medical College in New Delhi, India. She then completed a residency in Internal Medicine at the University of Connecticut Health Center. Dr. Gupta then completed a fellowship in Hematology-Oncology at Georgetown University in Washington, D.C., and Thomas Jefferson University in Philadelphia, Pennsylvania. She subsequently completed a research fellowship in Genitourinary Oncology Translational Research at Thomas Jefferson University.

Dr. Gupta also serves as the Co-Chair of the Hoosier Cancer Research Network (HCRN) Genitourinary Working Group and Co-Chair of the Case Comprehensive Cancer Center PRMC committee. She has led several Investigator Initiated Trials in Genitourinary Cancers and has leadership roles in numerous studies regarding bladder cancer. Dr. Gupta’s research has been published in peer-reviewed journals, including the Journal of Clinical Oncology, Lancet Oncology, Clinical Cancer Research, European Oncology, among others. She is the author of the American Urologic Association core curriculum for penile cancer and serves on the NCCN Guidelines Panel for Prostate Cancer. Dr. Gupta is active in several professional organizations, including the American Society of Clinical Oncology, American Urologic Association, American Association of Cancer Research, Society of Urologic Oncology, Society of Immunotherapy for Cancer, Bladder Cancer Advocacy Network, Prostate Cancer Foundation, and the European Society of Medical Oncology.